4//SEC Filing
van der Velden Peter 4
Accession 0001654954-20-011786
CIK 0001540159other
Filed
Nov 2, 7:00 PM ET
Accepted
Nov 3, 1:18 PM ET
Size
13.1 KB
Accession
0001654954-20-011786
Insider Transaction Report
Form 4
van der Velden Peter
Director10% Owner
Transactions
- Exercise of In-Money
Common Shares
2020-11-02$4.00/sh+64,362$257,448→ 1,897,428 total(indirect: By IRA) - Exercise of In-Money
Common Shares
2020-11-02$4.00/sh+5,952$23,808→ 175,454 total(indirect: By IRA) - Exercise of In-Money
Common Share Warrants (Right to Buy)
2020-11-02−64,362→ 0 total(indirect: By IRA)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (64,362 underlying) - Exercise of In-Money
Common Share Warrants (Right to Buy)
2020-11-02−5,952→ 0 total(indirect: By IRA)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (5,952 underlying)
Transactions
- Exercise of In-Money
Common Shares
2020-11-02$4.00/sh+5,952$23,808→ 175,454 total(indirect: By IRA) - Exercise of In-Money
Common Shares
2020-11-02$4.00/sh+64,362$257,448→ 1,897,428 total(indirect: By IRA) - Exercise of In-Money
Common Share Warrants (Right to Buy)
2020-11-02−5,952→ 0 total(indirect: By IRA)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (5,952 underlying) - Exercise of In-Money
Common Share Warrants (Right to Buy)
2020-11-02−64,362→ 0 total(indirect: By IRA)Exercise: $4.00From: 2020-07-08Exp: 2020-11-08→ Common Shares (64,362 underlying)
Footnotes (1)
- [F1]This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001778046
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 7:00 PM ET
- Accepted
- Nov 3, 1:18 PM ET
- Size
- 13.1 KB